Biotechnology Sector

Cells behave like crowded cities, yet many crucial molecular conversations have been impossible to watch directly in real time. Traditional microscopy often averages enzyme activity across a whole cell, hiding where reactions actually occur—down to tiny nanodomains where signaling is decided. A team at the University of Illinois Chicago has now introduced an imaging strategy

In a finding that challenges a popular sports supplement’s reputation, researchers report that exogenous creatine can accelerate tumor metastasis through an unexpected signaling route. The work, published in Nature Communications (2026), links creatine supplementation to changes in how megakaryocytes—blood-cell precursors best known for clotting—communicate with cancer cells. The study focuses on a pathway centered on

A new study reports that functional MRI can reveal how deep brain stimulation (DBS) in the globus pallidus internus (GPi) engages distinct, target-dependent brain circuits. The work, led by Santyr and colleagues, uses active GPi DBS while participants undergo fMRI, offering a systems-level view of stimulation effects that goes beyond electrode placement and clinical symptom

Urban rivers are vital for biodiversity, local climate regulation, and everyday water supply, yet many are increasingly pressured by eutrophication. This nutrient-driven process can accelerate algal blooms, reduce dissolved oxygen, and degrade water quality. Traditional monitoring relies on labor-intensive sampling and laboratory analysis, which often produces sparse data and misses rapid spatial changes along entire

Ampyrone—an NSAID-related compound—has emerged as a promising way to enhance melanin production in human skin, according to a preclinical study led by Weill Cornell Medicine and National Eye Institute investigators. The work points toward an ampyrone-derived therapy for hypopigmentation disorders, where melanin levels are abnormally low or absent. Hypopigmentation can occur in severe genetic forms

A gene therapy aimed at correcting fragile X syndrome by restoring the missing FMR1 protein has demonstrated multiple disease-relevant improvements in a mouse model, according to a new study in Gene Therapy. Fragile X syndrome, the most common inherited form of intellectual disability and a major single-gene contributor linked to autism, currently has no cure;

A new evolutionary study is upending a century-old assumption about how vertebrate muscles work. For decades, researchers have treated muscle contraction as a largely conserved machine across animals: myosin pulls on actin to generate force, and the basic biochemical partnership was presumed to be nearly identical in birds, reptiles, amphibians, and fish. But by mining

The U.S. National Science Foundation (NSF) has selected Connecticut as one of twelve regions to receive an NSF Regional Innovation Engines (NSF Engines) award, positioning the state to accelerate critical technology development and strengthen U.S. competitiveness. At the center of the investment is the NSF Quantum Technologies Engine in Connecticut, known as the QuantumCT Engine.

Seattle-based Fred Hutch Cancer Center has announced $975,000 in internal Evergreen Fund support for eight research teams, aiming to translate promising laboratory findings into near-clinical and commercially relevant applications. The program is designed to de-risk early discovery, accelerate evidence generation, and connect investigators with industry partners and venture capital. This year’s selections were chosen by

Higher cultural engagement is linked with lower physiological ageing, according to an online analysis in the Journal of Epidemiology and Community Health. The finding reframes “ageing” as more than chronological time, focusing instead on how rapidly the body appears to be ageing at the biomarker level. Physiological age is intended to capture functional wear-and-tear across

Lockdown birth cohort research is adding new evidence to the long-running debate over how early-life disruptions shape later development. A study published online in Archives of Disease in Childhood reports that children born during England’s first COVID-19 lockdown showed lower levels of executive function—cognitive skills used for planning, problem solving and adapting to changing demands—than

Semiconductor surfaces—especially silicon and germanium (100)—owe much of their chemistry to a seemingly simple motif: the “buckled dimer.” In this arrangement, two surface atoms form a pair with opposing electronic tendencies: a Lewis-acidic “down” atom and a Lewis-basic “up” atom. That polarization is central to how these materials behave during passivation, chemical functionalization, and device

Personalized AI is moving from a promise to a practical reality: more people and companies want assistants trained on their own files, preferences, and knowledge. But tailoring a large language model (LLM) to new data can quietly erode safety—customization improves usefulness while sometimes weakening the safeguards that prevent harmful answers. KAIST researchers say they have

A new genetics study from the University of Nottingham reports that a popular pet gecko—an exceptional “lemon frost” morph of the leopard gecko—has an unusually high natural tendency to develop aggressive tumors. The researchers argue that the species could become a powerful comparative model for understanding how cancer arises and spreads. The work, published in

Driven by the urgent need for safe, large-scale energy storage, zinc-ion batteries (ZIBs) are gaining momentum as a “post-lithium” alternative. Their appeal lies in intrinsic safety, environmental compatibility, and high theoretical capacity. Yet commercial progress remains constrained by interfacial instability: zinc dendrites can grow unpredictably, parasitic side reactions such as corrosion and hydrogen evolution can

Around three million people worldwide live with chronic pancreatitis, a debilitating condition marked by persistent inflammation, scarring, and severe pain. Once established, the disease is notoriously hard to reverse, leaving patients with limited options and researchers with a pressing need for more precise, mechanism-based therapies. In a new study in Cell Stem Cell (June 30,

Why the immune system wanes with age remains one of biology’s most persistent puzzles. A new USC study, published in BMC Biology, narrows the question to a single, widely distributed immune workhorse: macrophages. These cells patrol nearly every tissue, clearing debris, coordinating defenses, and tuning inflammation. Yet their function does not stay constant across the

AI speech-to-text is moving from novelty to routine in healthcare, but a new wave of scrutiny is keeping pace. The technology gained mainstream attention earlier this year through the medical drama “The Pitt,” where a clinician demonstrates an AI tool that dramatically reduces time spent on documentation. A single misheard medication name also exposes how

Multiple myeloma has long been puzzling: two patients with “the same” diagnosis can diverge dramatically in progression and therapy response. A new study from The University of Texas MD Anderson Cancer Center tackles this problem by looking past the cancer cells alone and instead charting the immune ecosystem living inside bone marrow. Using advanced single-cell

TUCSON, Ariz., July 14, 2026 — Critical Path Institute® (C-Path) announced that its Board of Directors has elected Karen Bernstein, Ph.D., as chair effective July 1, 2026. Bernstein succeeds M. Wainwright Fishburn, Jr., J.D., who concluded a five-year term guiding the organization through a period of major expansion and international regulatory engagement. Bernstein is a

With a major restructuring currently underway, we take a look at Takeda's pipeline strategy – including three planned major drug launches. The post Inside Takeda’s transformation: The pipeline strategy behind its next growth chapter appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Explore how Curia tackles steroid manufacturing complexity, from early development to scaled, end-to-end commercial supply. The post End-to-end: Curia drives supply and scale for steroid and hormonal therapies appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Discover eight biotech companies at the forefront of Poland’s emerging biotech sector, which is becoming a hotspot for startups. The post Eight biotechnology companies leading the charge in Poland appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

June 2026 saw drug development in oncology and neurology continue and biotech deals over small molecules and RNA therapies were forged. The post Top biotech deals in June 2026  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Today, we are with Andy Parker, CEO of Step Pharma, and we'll discuss a targeted approach to cancer an the future of precision oncology. The post Turning cancer cell dependencies into targeted therapies appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Explore Denmark's dynamic biotech scene with 10 innovative companies at the forefront of the biopharmaceutical revolution! The post 11 biotech companies leading the way in Denmark appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of research starts. The post The hidden innovation system behind drug repurposing  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Discover how Customer Experience Centers (CECs) are reshaping genomics and biotech in Europe by bridging innovation and implementation across labs. The post Why Customer Experience Centers are becoming practical infrastructure for life sciences innovation in Europe appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Parabilis Medicines, NewLimit, Enliven Therapeutics, and Kardigan bagged the biggest biotech funding rounds overall in June 2026. The post The biggest biotech funding rounds in June 2026 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Find out what Novartis' pipeline strategy since it spun off its biosimilars and generics business Sandoz, and engage in intensive dealmaking. The post Novartis’ strategy in 2026: rebuilding the pipeline after Entresto  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Today I'm sitting down with Randy Teel, Ph.D., President and CEO of Arvinas, a clinical-stage biotech, pioneering PROTAC protein degradation. The post The first PROTAC is here. What comes next in protein degradation? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Discover Prague's biotech hub, now viewed as the primary ‘entry gateway’ into the wider Central and Eastern European biopharma market. The post Prague: The up-and-coming biotech hub in Central Europe appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.

Navigating the Complex World of Global Drug Patents: Strategies and Challenges Ahead As a pharmaceutical professional, you know how crucial it is to protect your innovative drug patents in the global market. With the rise of international trade and the... Source

The Complex World of Biologic Drugs: Navigating Patent Applications As a biotech professional, you're likely no stranger to the intricacies of developing life-saving treatments. But when it comes to biologic drugs, the process can be particularly chall... Source

Unlocking the Power of Combination Therapies: Strategies for Successful Patenting As a pharmaceutical professional, you know that combination therapies have revolutionized the treatment of complex diseases. By pairing two or more active ingredients, yo... Source

The Secret to Setting the Right Price for Your Generic Medications As a generic drug manufacturer, you're constantly looking for ways to stay ahead of the competition and bring affordable medications to market. But have you ever wondered how to set the... Source

Unlocking Efficiency in the Generic Drug Supply Chain As the pharmaceutical industry continues to evolve, the generic drug supply chain has become a critical component of ensuring timely and affordable access to life-saving medications. However, naviga... Source

Breaking News: FDA Updates - What Do the Latest Changes Mean for Generic Drug Approval? As a healthcare professional or a business leader in the pharmaceutical industry, you're likely aware of the complex landscape surrounding generic drug approval. Re... Source

Breaking Down Barriers: Navigating Regulatory Challenges in Latin America's Generic Drug Market As the demand for affordable generic medications continues to grow, Latin America has emerged as a critical region for pharmaceutical companies looking to e... Source

The Future of Affordable Healthcare: Can Biosimilars Deliver? As healthcare professionals, we're constantly on the lookout for innovative solutions to improve patient outcomes while reducing costs. One promising approach is the use of biosimilars – bio... Source

Ensuring the Highest Quality in Generic Medications: A Crucial Step in Healthcare As the global demand for affordable healthcare continues to rise, generic medications have become a vital lifeline for millions of people worldwide. However, with the inc... Source

The Unseen Heroes of Generic Medicines: The Crucial Role of Quality Assurance As we navigate the complex world of pharmaceuticals, it's easy to overlook the unsung heroes behind the scenes. But today, I want to shine a spotlight on the Quality Assuranc... Source

Can Lurbinectedin Treat Ovarian Cancer? A Comprehensive Review Ovarian cancer is a devastating disease that affects thousands... https://www.Drugchatter.com/chat/25460/can-lurbinectedin-treat-ovarian-cancer/ Source

Unlocking the Potential of Biosimilars: Navigating Regulatory Considerations for Clinical Efficacy Trials As the pharmaceutical industry continues to evolve, biosimilars have emerged as a game-changer in the quest for affordable and accessible treatmen... Source

Unlock the Secrets of Drug Patent Searching: A Beginner's Guide As a professional in the pharmaceutical industry, staying ahead of the curve is crucial. One of the most critical aspects of this is understanding the world of drug patents. But have you e... Source

Unlocking the Path to Generic Medication Approval: A Step-by-Step Guide As a healthcare professional or a business leader in the pharmaceutical industry, you're likely aware of the complex landscape surrounding generic medication approval. With the eve... Source

The Future of Biosimilars: Switching Strategies for Success As the biosimilar market continues to grow, one question on everyone's mind is: how can we make the most of this opportunity? One strategy that's gaining traction is biosimilar-to-biosimilar s... Source

The Hidden Factors Behind FDA-Approved Drugs' Patent Challenges As a healthcare professional or a pharmaceutical industry expert, you're likely no stranger to the complex world of drug patents. But have you ever wondered what sets some FDA-approved dru... Source

Breaking Down Barriers: The Power of Partnerships in Generic Drug Development As the pharmaceutical industry continues to evolve, one thing is clear: collaboration is key. In the world of generic drug development, partnerships are playing an increasing... Source

Does Fish Oil Interact with Vascepa? A Comprehensive Guide As the world becomes increasingly aware of the importance of... https://www.Drugchatter.com/chat/45752/does-fish-oil-interact-with-vascepa/ Source

The Art of Timing: Mastering Generic Drug Development Timelines As a seasoned professional in the pharmaceutical industry, you know that navigating the complex landscape of generic drug development can be a daunting task. One of the most critical facto... Source

The Impact of Lipitor on White Wine: A Comprehensive Guide As a popular cholesterol-lowering medication, Lipitor (atorvastatin)... https://www.Drugchatter.com/chat/37341/how-does-lipitor-affect-white-wine/ Source

With significant growth in activities globally, our /local page has strained to keep up and simply is not a great...